Impact of Ozanimod on Fecal Calprotectin Levels and the Association With Efficacy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 True North Study

被引：0
|
作者：
Harris, Sarah [1 ]
Maddux, Rachel [1 ]
Li, Yicong [2 ]
Hu, Sarah [1 ]
Wu, Chun [1 ]
Petersen, AnnKatrin [1 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Parexel Int, Durham, NC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S780
引用
收藏
页码：S556 / S556
页数：1
相关论文
共 50 条
  • [41] Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2TOUCHSTONE Study
    Sandborn, William J.
    Feagan, Brian G.
    Hanauer, Stephen
    Vermeire, Severine
    Ghosh, Subrata
    Liu, Wenzhong J.
    Petersen, AnnKatrin
    Charles, Lorna
    Huang, Vivian
    Usiskin, Keith
    Wolf, Douglas C.
    D'Haens, Geert
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (07): : 1120 - 1129
  • [42] Impact of recent thiopurine use on ozanimod safety in patients with ulcerative colitis: a post hoc analysis of the phase 3 True North study
    Battat, R.
    Panaccione, R.
    Hart, A.
    Hisamatsu, T.
    Ahmad, H. A.
    Osterman, M. T.
    Wu, H.
    Jain, A.
    Rosen, M.
    Siegmund, B.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1100 - I1101
  • [43] Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study
    Louis, Edouard
    Panaccione, Remo
    Parkes, Gareth
    Pevrin-Biroulet, Laurent
    Ferrante, Marc
    Takeuchi, Ken
    Siegmund, Britta
    Levine, Phillip
    Kalabic, Jasmina
    Neimark, Ezequiel
    Wallace, Kori
    Chen, Su
    Duan, W. Rachel
    Armuzzi, Alessandro
    Biedermann, Luc
    Loftus, Edward
    Melmed, Gil
    Schreiber, Stefan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S3 - S3
  • [44] Association of Faecal Calprotectin With Symptomatic, Endoscopic, and Clinical Remission in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab
    Vermeire, Severine
    Long, Millie D.
    Dulai, Parambir S.
    Ma, Christopher
    Chan-diehl, Faye
    Moses, Richard
    Zhu, Baojin
    Paulissen, Jerome
    Travis, Simon
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S958 - S958
  • [45] Association Between Fecal Calprotectin Cutoff Concentrations of 150 or 250 μg/g and Ozanimod Efficacy: A Post Hoc Analysis of the Phase 3 True North Study
    Yarur, Andres
    Dubinsky, Marla C.
    Ghosh, Subrata
    Arsenescu, Razvan
    Zeissig, Sebastian
    Liu, Zhaohui
    Harris, Sarah
    Mehra, Dimpy
    Jain, Anjali
    Ananthakrishnan, Ashwin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S775 - S776
  • [46] Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies
    Chua, Laiyi
    Friedrich, Stuart
    Zhang, Xin Cindy
    CLINICAL PHARMACOKINETICS, 2023, : 1479 - 1491
  • [47] Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies
    Chua, Laiyi
    Friedrich, Stuart
    Zhang, Xin Cindy
    CLINICAL PHARMACOKINETICS, 2023,
  • [48] Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies
    Laiyi Chua
    Stuart Friedrich
    Xin Cindy Zhang
    Clinical Pharmacokinetics, 2023, 62 (10) : 1479 - 1491
  • [49] Ozanimod Efficacy and Safety in Older Patients With Ulcerative Colitis: A Post Hoc Analysis From True North
    Khan, Nabeel
    Irving, Peter
    Blumenstein, Irina
    Horst, Sara
    Ahmad, Harris
    Lawlor, Garrett
    Hobbs, Vanessa
    Jain, Anjali
    Memaj, Arteid
    Ananthakrishnan, Ashwin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S25 - S25
  • [50] Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance Study
    Vermeire, Severine
    Danese, Silvio
    Zhou, Wen
    Yao, Xuan
    Ilo, Dapo
    Liu, John
    Hebuterne, Xavier
    Lindsay, James
    Sanchez-Gonzalez, Yuri
    Higgins, Peter D.
    Colombel, Jean-Frederic
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S521 - S522
12345